Dawnrays Pharmaceutical (Holdings) Limited

Announcements & Notices       

2020-December-2	UPDATE ON JOINT VENTURE COMPANY-EARLY COMPLETION OF PATIENT ENROLLMENT IN PHASE IIB CLINICAL TRIAL FOR EBRONUCIMAB (PCSK9 INHIBITORS) FOR TREATING PATIENTS SUFFERING FROM HIGH- OR VERY HIGH-RISK HYPERCHOLESTEROLEMIA IN THE PRC (in PDF)
2020-August-26	GRANT OF OPTIONS (in PDF)
2020-August-25	Announcement of Interim Results for the Six months ended 30 June 2020 (in PDF)
2020-August-20	SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2019 ANNUAL REPORT (in PDF)
2020-August-14	DISCLOSEABLE TRANSACTION-CONSTRUCTION AGREEMENTS (in PDF)
2020-August-12	DATE OF BOARD MEETING (in PDF)
2020-June-25	DISCLOSEABLE TRANSACTION-CONSTRUCTION AGREEMENT (in PDF)
2020-June-24	UPDATE ON JOINT VENTURE COMPANY AND SUPPLEMENTAL AGREEMENT TO JV AGREEMENT (in PDF)
2020-June-8	CHANGE IN BOARD LOT SIZE (in PDF)
2020-May-29	POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2020 (in PDF)
2020-April-22	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2020-March-27	ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019 (in PDF)
2020-March-16	DATE OF BOARD MEETING (in PDF)
2020-January-2	UPDATED INFORMATION OF THE GROUP'S PRODUCT (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices